Severn Trent PLC (LON:SVT – Get Free Report) insider Richard Taylor acquired 1,800 shares of the business’s stock in a transaction on Monday, June 9th. The stock was acquired at an average cost of GBX 2,636 ($35.89) per share, for a total transaction of £47,448 ($64,599.05).
Severn Trent Trading Up 0.2%
Shares of LON SVT opened at GBX 2,727.42 ($37.13) on Friday. The company has a debt-to-equity ratio of 450.94, a current ratio of 2.14 and a quick ratio of 0.73. The stock has a market capitalization of £8.14 billion, a P/E ratio of 45.52, a price-to-earnings-growth ratio of 4.69 and a beta of 0.38. Severn Trent PLC has a 1-year low of GBX 2,323 ($31.63) and a 1-year high of GBX 2,807 ($38.22). The business has a fifty day moving average price of GBX 2,685.64 and a 200 day moving average price of GBX 2,568.74.
Severn Trent (LON:SVT – Get Free Report) last released its quarterly earnings results on Wednesday, May 21st. The company reported GBX 112.10 ($1.53) EPS for the quarter. Severn Trent had a return on equity of 10.40% and a net margin of 6.00%. Equities research analysts expect that Severn Trent PLC will post 107.3706004 EPS for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on SVT
Severn Trent Company Profile
As one of Britain’s largest water companies, we provide over eight million people across our region with fresh, clean drinking water – about two billion litres every day. And when they’ve finished with it, we take it away again then clean and treat it before returning it safely back to the environment.
We are one of only three listed water stocks in the UK, offering a valuable combination of reliable earnings, long term asset growth and an inflation-linked dividend.
Recommended Stories
- Five stocks we like better than Severn Trent
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Severn Trent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Severn Trent and related companies with MarketBeat.com's FREE daily email newsletter.